Herantis Pharma Oyj (HRTIS) - Total Liabilities

Latest as of June 2025: €3.36 Million EUR ≈ $3.93 Million USD

Based on the latest financial reports, Herantis Pharma Oyj (HRTIS) has total liabilities worth €3.36 Million EUR (≈ $3.93 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Herantis Pharma Oyj long-term investment intensity to see how much of total assets are deployed in long-term investments.

Herantis Pharma Oyj - Total Liabilities Trend (2011–2024)

This chart illustrates how Herantis Pharma Oyj's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see balance sheet size of Herantis Pharma Oyj.

Herantis Pharma Oyj Competitors by Total Liabilities

The table below lists competitors of Herantis Pharma Oyj ranked by their total liabilities.

Company	Country	Total Liabilities
Raphas Co. Ltd KQ:214260	Korea	₩40.43 Billion
Histeel KO:071090	Korea	₩128.70 Billion
Seondo Electric Co., Ltd. KO:007610	Korea	₩38.06 Billion
BlockchAIn Digital Infrastructure, Inc NYSE MKT:AIB	USA	$9.41 Million
PASSUS S.A. ZY-1 F:71X	Germany	€37.95 Million
Jembo Cable Company Tbk JK:JECC	Indonesia	Rp1.66 Trillion
HILONG HOLDING LTD HD-10 F:8HL	Germany	€4.68 Billion
Samkee Automotive Co. Ltd KQ:122350	Korea	₩569.21 Billion

Liability Composition Analysis (2011–2024)

This chart breaks down Herantis Pharma Oyj's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Herantis Pharma Oyj (HRTIS) net asset quality to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	8.10	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	0.71	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.92	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.66	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Herantis Pharma Oyj's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Herantis Pharma Oyj (2011–2024)

The table below shows the annual total liabilities of Herantis Pharma Oyj from 2011 to 2024.

Year	Total Liabilities	Change
2024-12-31	€2.81 Million ≈ $3.29 Million	+39.36%
2023-12-31	€2.02 Million ≈ $2.36 Million	-67.91%
2022-12-31	€6.29 Million ≈ $7.36 Million	-1.12%
2021-12-31	€6.36 Million ≈ $7.44 Million	-27.95%
2020-12-31	€8.83 Million ≈ $10.33 Million	-4.19%
2019-12-31	€9.22 Million ≈ $10.78 Million	+27.40%
2018-12-31	€7.24 Million ≈ $8.46 Million	-3.28%
2017-12-31	€7.48 Million ≈ $8.75 Million	-13.31%
2016-12-31	€8.63 Million ≈ $10.09 Million	+6.69%
2015-12-31	€8.09 Million ≈ $9.46 Million	+4.05%
2014-12-31	€7.77 Million ≈ $9.09 Million	+208.39%
2013-12-31	€2.52 Million ≈ $2.95 Million	+13.82%
2012-12-31	€2.21 Million ≈ $2.59 Million	+15.35%
2011-12-31	€1.92 Million ≈ $2.24 Million	--

About Herantis Pharma Oyj

HE:HRTIS Finland Biotechnology

Market Cap

$43.69 Million

€37.37 Million EUR

Market Cap Rank

#22500 Global

#112 in Finland

Share Price

€1.41

Change (1 day)

-1.40%

52-Week Range

€1.41 - €2.78

All Time High

€10.10